GlassScriptPhysician profile
Gregory M Swank
NPI 1720030976
$7,536.29
in general payments reported to CMS, 2019-2025
29 companies · $778 in 2025
The $778 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,730 · 2020: $179 · 2021: $785 · 2022: $1,345 · 2023: $1,262 · 2024: $457 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,355.94 | 2019-2022 | |
| Mentor Worldwide LLC | $2,339.97 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medical Device Business Services, INC. | $1,009.85 | 2022 | |
| Tela Bio, INC. | $342.72 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $275.22 | 2020-2025 | Natrelle Saline-Filled Breast Implants |
| Galderma Laboratories, L.P. | $274.89 | 2019-2023 | Dysport |
| Integra Lifesciences Corporation | $163.67 | 2023 | Durasorb Monofilament Mesh |
| Motiva USA, LLC | $115.84 | 2025 | |
| Leo Pharma INC. | $73.79 | 2022-2025 | Adbry |
| Organogenesis INC. | $69.45 | 2023-2024 | Puraply, Apligraf |
| Convatec INC. | $68.09 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $53.70 | 2019-2023 | Blu-U, Odomzo |
| Vyne Pharmaceuticals INC. | $46.89 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.61 | 2023-2024 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $40.70 | 2023-2025 | Libtayo |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $39.14 | 2019 | |
| Ucb, INC. | $29.94 | 2025 | Bimzelx |
| Sandoz INC. | $27.06 | 2023 | Hyrimoz |
| Stryker Corporation | $25.30 | 2025 | Mako |
| Merck Sharp & Dohme LLC | $19.51 | 2024 | Keytruda |
| Davol INC. | $15.37 | 2021 | |
| Sientra, INC. | $15.18 | 2020-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Medtronic, INC. | $13.67 | 2024 | V-Loc 180 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.66 | 2020 | |
| Mylan Pharmaceuticals INC. | $13.44 | 2019 | |
| Baxter Healthcare | $13.18 | 2023 | Artiss |
| Janssen Biotech, INC. | $12.42 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.68 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Swank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.